Fanconi anaemia and cancer: an intricate relationship

G Nalepa, DW Clapp - Nature Reviews Cancer, 2018 - nature.com
Fanconi anaemia (FA) is a genetic disorder that is characterized by bone marrow failure
(BMF), developmental abnormalities and predisposition to cancer. Together with other …

Molecular pathogenesis and clinical management of Fanconi anemia

Y Kee, AD D'Andrea - The Journal of clinical investigation, 2012 - Am Soc Clin Investig
Fanconi anemia (FA) is a rare genetic disorder associated with a high frequency of
hematological abnormalities and congenital anomalies. Based on multilateral efforts from …

Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function

JI Garaycoechea, GP Crossan, F Langevin, M Daly… - Nature, 2012 - nature.com
Haematopoietic stem cells (HSCs) regenerate blood cells throughout the lifespan of an
organism. With age, the functional quality of HSCs declines, partly owing to the …

FANCD2 protects against bone marrow injury from ferroptosis

X Song, Y **e, R Kang, W Hou, X Sun… - Biochemical and …, 2016 - Elsevier
Bone marrow injury remains a serious concern in traditional cancer treatment. Ferroptosis is
an iron-and oxidative-dependent form of regulated cell death that has become part of an …

BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair

SF Bunting, E Callén, ML Kozak, JM Kim, N Wong… - Molecular cell, 2012 - cell.com
Brca1 is required for DNA repair by homologous recombination (HR) and normal embryonic
development. Here we report that deletion of the DNA damage response factor 53BP1 …

TGF-β inhibition rescues hematopoietic stem cell defects and bone marrow failure in Fanconi anemia

H Zhang, DE Kozono, KW O'Connor, S Vidal-Cardenas… - Cell stem cell, 2016 - cell.com
Fanconi anemia (FA) is an inherited DNA repair disorder characterized by progressive bone
marrow failure (BMF) from hematopoietic stem and progenitor cell (HSPC) attrition. A greater …

[HTML][HTML] Resveratrol counteracts bone loss via mitofilin-mediated osteogenic improvement of mesenchymal stem cells in senescence-accelerated mice

YJ Lv, Y Yang, BD Sui, CH Hu, P Zhao, L Liao… - Theranostics, 2018 - ncbi.nlm.nih.gov
Rational: Senescence of mesenchymal stem cells (MSCs) and the related functional decline
of osteogenesis have emerged as the critical pathogenesis of osteoporosis in aging …

A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis

A Gueiderikh, F Maczkowiak-Chartois, F Rosselli - Blood reviews, 2022 - Elsevier
Abstract Described by Guido Fanconi almost 100 years ago, Fanconi anemia (FA) is a rare
genetic disease characterized by developmental abnormalities, bone marrow failure (BMF) …

Why does the bone marrow fail in Fanconi anemia?

JI Garaycoechea, KJ Patel - … Journal of the American Society of …, 2014 - ashpublications.org
The inherited bone marrow failure (BMF) syndromes are a rare and diverse group of genetic
disorders that ultimately result in the loss of blood production. The molecular defects …

Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells

D Carrero, C Soria-Valles… - Disease models & …, 2016 - journals.biologists.com
Ageing is a process that inevitably affects most living organisms and involves the
accumulation of macromolecular damage, genomic instability and loss of heterochromatin …